Top 10 Stocks That Could Make You a Millionaire by 2030

Microsoft's $13 billion bet on OpenAI transformed the company from a legacy software giant into the undisputed enterprise AI leader. Azure cloud revenue is growing at 30%+ per year, fueled by AI services demand. Microsoft 365 Copilot is being deployed by thousands of Fortune 500 companies at $30/user/month — a revenue stream that barely existed in 2023. With $60 billion in annual operating cash flow, Microsoft can fund its AI ambitions while rewarding shareholders.

Eli Lilly's GLP-1 drugs — Mounjaro for diabetes and Zepbound for obesity — may be the biggest pharmaceutical breakthrough since statins. The global obesity drug market is projected to reach $130 billion by 2030, and Lilly is manufacturing as fast as humanly possible to keep up with demand. The company raised its full-year 2024 revenue guidance to $45.4 billion, a 36% increase, while analysts see the stock doubling again by decade's end.

Amazon Web Services generates over $100 billion in annual revenue and still growing at 17% — yet it trades at a fraction of pure-play cloud competitors. CEO Andy Jassy is ruthlessly cutting costs while AI investment pays off: Amazon's Bedrock platform and custom Trainium chips are making AWS the enterprise AI cloud of choice. Add in the advertising business growing 18% annually and healthcare ambitions via Amazon Pharmacy and One Medical, and this is a decade-long compounder.

ASML is the only company in the world that makes Extreme Ultraviolet lithography machines — the equipment needed to manufacture the world's most advanced chips. Without ASML, there is no Apple M4, no Nvidia H100, no next-generation semiconductor. This complete monopoly in critical infrastructure gives ASML pricing power that borders on supernatural. With a backlog exceeding €36 billion and every chip fab on the planet needing their machines, ASML's moat is measured not in years, but in decades.

Broadcom is quietly becoming the second-largest AI chip company behind Nvidia. Google, Meta, Apple, and ByteTok all rely on Broadcom for custom AI accelerator chips (ASICs), and the company is reportedly designing billions of dollars' worth of next-generation AI silicon. The $69 billion acquisition of VMware has also transformed Broadcom into a dominant enterprise software business, generating recurring subscription revenues that make its earnings highly predictable.

Palantir has cracked the code on enterprise and government AI adoption. Its Artificial Intelligence Platform (AIP) is winning deals at an extraordinary rate — U.S. commercial revenue grew 55% in Q3 2024 alone. The company has been profitable for eight consecutive quarters and recently joined the S&P 500. Analysts see Palantir as the operating system for AI in national security and enterprise — a position that cannot be easily replicated or displaced by Big Tech competitors.

Intuitive Surgical's da Vinci robotic surgery systems are installed in 9,000+ hospitals worldwide, and each installation generates a razor-and-blades revenue model: sell the robot once, then collect recurring fees from instruments, accessories, and services. Revenue per installed system grows every year as surgeons perform more procedures. The next-generation da Vinci 5 launched in 2024 to strong demand, and the company sits on $6 billion in cash with zero debt.

Tesla's Full Self-Driving subscription and its planned robotaxi network represent a potential revenue stream that dwarfs its car business. A single robotaxi fleet generating $1/mile at scale across millions of vehicles could add trillions to Tesla's valuation. Meanwhile, the company's Megapack energy storage business is growing 140% annually — making Tesla as much an energy company as an automaker. If FSD works, Tesla may be the most undervalued stock on this entire list.

Warren Buffett's conglomerate is sitting on over $325 billion in cash — a war chest that has never been larger in the company's history. Berkshire owns dominant positions in American Express, Coca-Cola, Bank of America, and Apple, while its insurance operations generate perpetual float. If markets crash or interest rates shift, Berkshire will deploy that cash into acquisitions that could supercharge returns. At 93, Buffett has built an institution that is designed to outlast any individual — including himself.

Microsoft's $13 billion bet on OpenAI transformed the company from a legacy software giant into the undisputed enterprise AI leader. Azure cloud revenue is growing at 30%+ per year, fueled by AI services demand. Microsoft 365 Copilot is being deployed by thousands of Fortune 500 companies at $30/user/month — a revenue stream that barely existed in 2023. With $60 billion in annual operating cash flow, Microsoft can fund its AI ambitions while rewarding shareholders.

Eli Lilly's GLP-1 drugs — Mounjaro for diabetes and Zepbound for obesity — may be the biggest pharmaceutical breakthrough since statins. The global obesity drug market is projected to reach $130 billion by 2030, and Lilly is manufacturing as fast as humanly possible to keep up with demand. The company raised its full-year 2024 revenue guidance to $45.4 billion, a 36% increase, while analysts see the stock doubling again by decade's end.

Amazon Web Services generates over $100 billion in annual revenue and still growing at 17% — yet it trades at a fraction of pure-play cloud competitors. CEO Andy Jassy is ruthlessly cutting costs while AI investment pays off: Amazon's Bedrock platform and custom Trainium chips are making AWS the enterprise AI cloud of choice. Add in the advertising business growing 18% annually and healthcare ambitions via Amazon Pharmacy and One Medical, and this is a decade-long compounder.

ASML is the only company in the world that makes Extreme Ultraviolet lithography machines — the equipment needed to manufacture the world's most advanced chips. Without ASML, there is no Apple M4, no Nvidia H100, no next-generation semiconductor. This complete monopoly in critical infrastructure gives ASML pricing power that borders on supernatural. With a backlog exceeding €36 billion and every chip fab on the planet needing their machines, ASML's moat is measured not in years, but in decades.

Broadcom is quietly becoming the second-largest AI chip company behind Nvidia. Google, Meta, Apple, and ByteTok all rely on Broadcom for custom AI accelerator chips (ASICs), and the company is reportedly designing billions of dollars' worth of next-generation AI silicon. The $69 billion acquisition of VMware has also transformed Broadcom into a dominant enterprise software business, generating recurring subscription revenues that make its earnings highly predictable.

Palantir has cracked the code on enterprise and government AI adoption. Its Artificial Intelligence Platform (AIP) is winning deals at an extraordinary rate — U.S. commercial revenue grew 55% in Q3 2024 alone. The company has been profitable for eight consecutive quarters and recently joined the S&P 500. Analysts see Palantir as the operating system for AI in national security and enterprise — a position that cannot be easily replicated or displaced by Big Tech competitors.

Intuitive Surgical's da Vinci robotic surgery systems are installed in 9,000+ hospitals worldwide, and each installation generates a razor-and-blades revenue model: sell the robot once, then collect recurring fees from instruments, accessories, and services. Revenue per installed system grows every year as surgeons perform more procedures. The next-generation da Vinci 5 launched in 2024 to strong demand, and the company sits on $6 billion in cash with zero debt.

Tesla's Full Self-Driving subscription and its planned robotaxi network represent a potential revenue stream that dwarfs its car business. A single robotaxi fleet generating $1/mile at scale across millions of vehicles could add trillions to Tesla's valuation. Meanwhile, the company's Megapack energy storage business is growing 140% annually — making Tesla as much an energy company as an automaker. If FSD works, Tesla may be the most undervalued stock on this entire list.

Warren Buffett's conglomerate is sitting on over $325 billion in cash — a war chest that has never been larger in the company's history. Berkshire owns dominant positions in American Express, Coca-Cola, Bank of America, and Apple, while its insurance operations generate perpetual float. If markets crash or interest rates shift, Berkshire will deploy that cash into acquisitions that could supercharge returns. At 93, Buffett has built an institution that is designed to outlast any individual — including himself.